176 related articles for article (PubMed ID: 7821752)
1. Identification of specificity-determining residues in antibodies.
Padlan EA; Abergel C; Tipper JP
FASEB J; 1995 Jan; 9(1):133-9. PubMed ID: 7821752
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
3. Structural significance of sequence variability in antibody complementarity-determining regions.
Abergel C; Tipper JP; Padlan EA
Res Immunol; 1994 Jan; 145(1):49-53. PubMed ID: 8008969
[No Abstract] [Full Text] [Related]
4. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins.
Laune D; Molina F; Ferrieres G; Mani JC; Cohen P; Simon D; Bernardi T; Piechaczyk M; Pau B; Granier C
J Biol Chem; 1997 Dec; 272(49):30937-44. PubMed ID: 9388240
[TBL] [Abstract][Full Text] [Related]
5. Antibody framework residues affecting the conformation of the hypervariable loops.
Foote J; Winter G
J Mol Biol; 1992 Mar; 224(2):487-99. PubMed ID: 1560463
[TBL] [Abstract][Full Text] [Related]
6. A mutational analysis of the binding of two different proteins to the same antibody.
Dall'Acqua W; Goldman ER; Eisenstein E; Mariuzza RA
Biochemistry; 1996 Jul; 35(30):9667-76. PubMed ID: 8703938
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of antibody-combining sites.
Webster DM; Rees AR
Methods Mol Biol; 1995; 51():17-49. PubMed ID: 7581695
[No Abstract] [Full Text] [Related]
8. Comparison of surface accessible residues in human and murine immunoglobulin Fv domains. Implication for humanization of murine antibodies.
Pedersen JT; Henry AH; Searle SJ; Guild BC; Roguska M; Rees AR
J Mol Biol; 1994 Jan; 235(3):959-73. PubMed ID: 7507176
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.
Near RI; Mudgett-Hunter M; Novotny J; Bruccoleri R; Ng SC
Mol Immunol; 1993 Mar; 30(4):369-77. PubMed ID: 8455637
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.
Amit AG; Mariuzza RA; Phillips SE; Poljak RJ
Science; 1986 Aug; 233(4765):747-53. PubMed ID: 2426778
[TBL] [Abstract][Full Text] [Related]
11. "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28.
Tan P; Mitchell DA; Buss TN; Holmes MA; Anasetti C; Foote J
J Immunol; 2002 Jul; 169(2):1119-25. PubMed ID: 12097421
[TBL] [Abstract][Full Text] [Related]
12. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
Narayanan A; Sellers BD; Jacobson MP
J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
[TBL] [Abstract][Full Text] [Related]
13. The His-probe method: effects of histidine residues introduced into the complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values.
Ito W; Sakato N; Fujio H; Yutani K; Arata Y; Kurosawa Y
FEBS Lett; 1992 Aug; 309(1):85-8. PubMed ID: 1511750
[TBL] [Abstract][Full Text] [Related]
14. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
Saini SS; Farrugia W; Ramsland PA; Kaushik AK
Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
[TBL] [Abstract][Full Text] [Related]
15. The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure.
Chothia C; Lesk AM; Levitt M; Amit AG; Mariuzza RA; Phillips SE; Poljak RJ
Science; 1986 Aug; 233(4765):755-8. PubMed ID: 3090684
[TBL] [Abstract][Full Text] [Related]
16. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
17. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
18. Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes.
Ofran Y; Schlessinger A; Rost B
J Immunol; 2008 Nov; 181(9):6230-5. PubMed ID: 18941213
[TBL] [Abstract][Full Text] [Related]
19. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
[TBL] [Abstract][Full Text] [Related]
20. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
Kabat EA; Wu TT
J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
